A comparative analysis of pharmacists’ perspectives on codeine use and misuse – a three country survey

Simple item page
dc.contributor.authorCarney, Taraen_ZA
dc.contributor.authorWells, Johnen_ZA
dc.contributor.authorParry, Charles D. H.en_ZA
dc.contributor.authorMcGuinness, Padraigen_ZA
dc.contributor.authorHarris, Richarden_ZA
dc.contributor.authorVan Hout, Marie Claireen_ZA
dc.date.accessioned2018-04-03T06:34:30Z
dc.date.available2018-04-03T06:34:30Z
dc.date.issued2018-03-27
dc.date.updated2018-04-01T13:19:53Z
dc.descriptionCITATION: Carney, T., et al. 2018. A comparative analysis of pharmacists’ perspectives on codeine use and misuse – a three country survey. Substance Abuse Treatment, Prevention, and Policy, 13:12, doi:10.1186/s13011-018-0149-2.
dc.descriptionThe original publication is available at https://substanceabusepolicy.biomedcentral.com
dc.description.abstractBackground: The misuse of codeine is of increasing concern in a number of countries, particularly as this relates to over -the-counter pain and cough relief medication, and is also supplied as a prescription medicine. The study aimed to obtain and analyse the opinions and experience of pharmacy staff with regard to codeine misuse. Methods: A cross-sectional web-based survey of pharmacy staff’s perspectives on this issue was administered through professional or regulatory bodies and completed by samples drawn in South Africa (n = 124), Ireland (n = 464) and the United Kingdom (n = 129). Results: The majority of participants reported combination codeine-containing products as most popular, but significantly more pharmacy staff in South Africa reported codeine-containing cough syrups as most commonly popular (X2 = 122.7(2), p < 0.001). Codeine use was also seen significantly more of a public health problem in South Africa than in the other two countries (X2 = 7.6(2), p = 0.02). There was no difference across countries in the level of codeine misuse reported by pharmacy staff. Further findings indicate that professional training and education is desired, with unequivocal findings for the need for greater codeine control (X2 = 12.0(2), p = 0.002). Conclusion: In conclusion, there were some inter-country differences, but overall the findings seem to suggest that pharmacists across all three countries view codeine misuse as a problem among their customers. Recommendations centre on risk management, surveillance and staff training.en
dc.description.sponsorshipFunding from European Community’s Seventh Framework Programme FP7/2007–2013 under grant agreement no 611736.
dc.description.urihttps://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-018-0149-2
dc.description.versionPublisher's version
dc.format.extent8 pages ; illustrations
dc.identifier.citationCarney, T., et al. 2018. A comparative analysis of pharmacists’ perspectives on codeine use and misuse – a three country survey. Substance Abuse Treatment, Prevention, and Policy, 13:12, doi:10.1186/s13011-018-0149-2
dc.identifier.issn1747-597X (online)
dc.identifier.otherdoi:10.1186/s13011-018-0149-2
dc.identifier.urihttp://hdl.handle.net/10019.1/103248
dc.language.isoen_ZAen_ZA
dc.publisherBioMed Central
dc.rights.holderAuthors retain copyright
dc.subjectPain medicineen_ZA
dc.subjectSubstance abuse -- Medical careen_ZA
dc.subjectCodeine -- Drug useen_ZA
dc.subjectPharmacists -- Attitudesen_ZA
dc.titleA comparative analysis of pharmacists’ perspectives on codeine use and misuse – a three country surveyen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
carney_comparative_2018.pdf
Size:
645.45 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.95 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Psychiatry)